U.S. markets closed

ImmunoCellular Therapeutics, Ltd. (IMUC)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.7500-0.0600 (-7.41%)
At close: 3:44PM EST
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
12/31/2017
Total Revenue
0
0
Operating Expense
5,665
21,153
Operating Income
-5,665
-21,153
Net Non Operating Interest Income Expense
1.107
-878.003
Other Income Expense
-
7,719
Pretax Income
-5,664
-14,312
Tax Provision
-
0
Net Income Common Stockholders
-9,034
-17,682
Diluted NI Available to Com Stockholders
-9,034
-17,682
Basic EPS
-
-0.0123
Diluted EPS
-
-0.0123
Basic Average Shares
-
4,191
Diluted Average Shares
-
4,191
Total Operating Income as Reported
-5,665
-21,153
Total Expenses
5,665
21,153
Net Income from Continuing & Discontinued Operation
-5,664
-14,312
Normalized Income
-5,664
-14,312
Interest Income
1.107
4.68
Interest Expense
-
882.683
Net Interest Income
1.107
-878.003
EBIT
-5,664
-13,429
EBITDA
-5,650
-
Reconciled Depreciation
14.79
47.768
Net Income from Continuing Operation Net Minority Interest
-5,664
-14,312
Total Unusual Items Excluding Goodwill
-
7,719
Total Unusual Items
-
7,719
Normalized EBITDA
-5,650
-13,382
Tax Rate for Calcs
0
0
Tax Effect of Unusual Items
0
0